These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 34338567)

  • 41. Lymphatic transport of Methylnortestosterone undecanoate (MU) and the bioavailability of methylnortestosterone are highly sensitive to the mass of coadministered lipid after oral administration of MU.
    White KL; Nguyen G; Charman WN; Edwards GA; Faassen WA; Porter CJ
    J Pharmacol Exp Ther; 2009 Nov; 331(2):700-9. PubMed ID: 19696095
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Absorption and disposition of scutellarin in rats: a pharmacokinetic explanation for the high exposure of its isomeric metabolite.
    Gao C; Chen X; Zhong D
    Drug Metab Dispos; 2011 Nov; 39(11):2034-44. PubMed ID: 21810967
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Profiling the role of deacylation-reacylation in the lymphatic transport of a triglyceride-mimetic prodrug.
    Han S; Hu L; Quach T; Simpson JS; Trevaskis NL; Porter CJ
    Pharm Res; 2015 May; 32(5):1830-44. PubMed ID: 25446770
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Pharmacokinetic and tissue distribution study of scutellarin in rats].
    You HS; Dong YL; Xing JF; Zhang CL; Wang MY
    Zhongguo Zhong Yao Za Zhi; 2007 Aug; 32(16):1688-92. PubMed ID: 18027669
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Enhancing Oral Performance of Paclitaxel Lipid-Mimic Prodrug via Modulating Type of Fatty Acids.
    Miao YF; Ye Q; Zhang MY; Gao L; Wang XY; Zhong WX; Wang ZX; He ZG; Tian CT; Sun J
    Adv Healthc Mater; 2023 Jul; 12(19):e2203118. PubMed ID: 36929289
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Enhancing the intestinal membrane permeability of zanamivir: a carrier mediated prodrug approach.
    Gupta SV; Gupta D; Sun J; Dahan A; Tsume Y; Hilfinger J; Lee KD; Amidon GL
    Mol Pharm; 2011 Dec; 8(6):2358-67. PubMed ID: 21905667
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Intestinal lymphatic transport for drug delivery.
    Yáñez JA; Wang SW; Knemeyer IW; Wirth MA; Alton KB
    Adv Drug Deliv Rev; 2011 Sep; 63(10-11):923-42. PubMed ID: 21689702
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Chylomicron-pretended nano-bio self-assembling vehicle to promote lymphatic transport and GALTs target of oral drugs.
    Mao Y; Feng S; Li S; Zhao Q; Di D; Liu Y; Wang S
    Biomaterials; 2019 Jan; 188():173-186. PubMed ID: 30359884
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Different impacts of intestinal lymphatic transport on the oral bioavailability of structurally similar synthetic lipophilic cannabinoids: dexanabinol and PRS-211,220.
    Gershkovich P; Qadri B; Yacovan A; Amselem S; Hoffman A
    Eur J Pharm Sci; 2007 Aug; 31(5):298-305. PubMed ID: 17560096
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A novel cascade strategy using a nanonized targeted prodrug for enhanced oral delivery efficiency.
    Guo M; Yu S; Huang Y; Song H; Li M; Liu D; Fu Q; He Z
    Int J Pharm; 2020 Sep; 587():119638. PubMed ID: 32659406
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Oral bioavailability assessment and intestinal lymphatic transport of Org 45697 and Org 46035, two highly lipophilic novel immunomodulator analogues.
    Caliph SM; Faassen WA; Vogel GM; Porter CJ
    Curr Drug Deliv; 2009 Aug; 6(4):359-66. PubMed ID: 19534711
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ethylene glycol-linked amino acid diester prodrugs of oleanolic acid for PepT1-mediated transport: synthesis, intestinal permeability and pharmacokinetics.
    Cao F; Jia J; Yin Z; Gao Y; Sha L; Lai Y; Ping Q; Zhang Y
    Mol Pharm; 2012 Aug; 9(8):2127-35. PubMed ID: 22352697
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Increasing oral absorption of polar neuraminidase inhibitors: a prodrug transporter approach applied to oseltamivir analogue.
    Gupta D; Varghese Gupta S; Dahan A; Tsume Y; Hilfinger J; Lee KD; Amidon GL
    Mol Pharm; 2013 Feb; 10(2):512-22. PubMed ID: 23244438
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Intranasal administration of brain-targeted HP-β-CD/chitosan nanoparticles for delivery of scutellarin, a compound with protective effect in cerebral ischaemia.
    Liu S; Ho PC
    J Pharm Pharmacol; 2017 Nov; 69(11):1495-1501. PubMed ID: 28809432
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Pharmacokinetics of scutellarin and its derivant scutellarin ethyl ester in rats].
    Zhu LW; Liu XQ; Feng J; Gao HM; Yi H; Wang ZM; Meng QJ
    Zhongguo Zhong Yao Za Zhi; 2013 Oct; 38(19):3373-7. PubMed ID: 24422411
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Oral administration of tipranavir with long-chain triglyceride results in moderate intestinal lymph targeting but no efficient delivery to HIV-1 reservoir in mesenteric lymph nodes.
    Chu Y; Qin C; Feng W; Sheriston C; Jane Khor Y; Medrano-Padial C; Watson BE; Chan T; Ling B; Stocks MJ; Fischer PM; Gershkovich P
    Int J Pharm; 2021 Jun; 602():120621. PubMed ID: 33892057
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Propylene glycol-linked amino acid/dipeptide diester prodrugs of oleanolic acid for PepT1-mediated transport: synthesis, intestinal permeability, and pharmacokinetics.
    Cao F; Gao Y; Wang M; Fang L; Ping Q
    Mol Pharm; 2013 Apr; 10(4):1378-87. PubMed ID: 23339520
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Targeted delivery of lopinavir to HIV reservoirs in the mesenteric lymphatic system by lipophilic ester prodrug approach.
    Qin C; Chu Y; Feng W; Fromont C; He S; Ali J; Lee JB; Zgair A; Berton M; Bettonte S; Liu R; Yang L; Monmaturapoj T; Medrano-Padial C; Ugalde AAR; Vetrugno D; Ee SY; Sheriston C; Wu Y; Stocks MJ; Fischer PM; Gershkovich P
    J Control Release; 2021 Jan; 329():1077-1089. PubMed ID: 33091528
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Corrigendum: Triglyceride-mimetic prodrugs of buprenorphine enhance oral bioavailability via promotion of lymphatic transport.
    Quach T; Hu L; Han S; Lim SF; Senyschyn D; Yadav P; Trevaskis NL; Simpson JS; Porter CJH
    Front Pharmacol; 2022; 13():1014363. PubMed ID: 36133812
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The influence of intestinal lymphatic transport on the systemic exposure and brain deposition of a novel highly lipophilic compound with structural similarity to cholesterol.
    Caliph SM; Faassen FW; Porter CJ
    J Pharm Pharmacol; 2014 Oct; 66(10):1377-87. PubMed ID: 24821499
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.